AI Humanizer tools is a trusted solution with a proven record of successfully bypassing AI detectors such as GPTZero and ...

ProMIS Neurosciences (PMN) announced important progress in the PRECISE-AD Phase 1b clinical trial with the dosing of multiple patients with its ...

Rapid Enrollment and Dosing of First Patients Encouraging and Underscores Unmet Need for Better Treatment Options for Alzheimer’s Disease ...

TALTZ (ixekizumab), an IL-17A inhibitor by Eli Lilly, has shown strong market growth driven by increasing adoption in psoriasis, psoriatic arthritis, and axial spondyloarthritis. With expanding ...

CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune ...

Cantor Fitzgerald reissued their overweight rating on shares of Prothena (NASDAQ:PRTA – Free Report) in a research report ...

Investment analysts at HC Wainwright issued their Q4 2025 EPS estimates for Prothena in a research note issued to investors on Friday, February 21st. HC Wainwright analyst A. Fein expects that the ...

Sixty years ago, Life Magazine photographer Grey Villet photographed Richard and Mildred Loving, an interracial married ...

Drive to Survive redefined sports documentaries by blending high-octane drama with intimate behind-the-scenes access, turning ...

Ray Chase, Robbie Daymond, and Amanda Hufford talk all things Date Everything, from the game's origin to why it features 100 ...

For years, athletes have been subject to relentless scrutiny from traditional sports media, their stories filtered through a lens they couldn't control. But Deron Guidrey had a different vision. In ...